Ежедневный обзор рынка от GT Capital | Аналитические обзоры

Ближайший уровень поддержки по SPY – 193.25 уровень сопротивления – 194.00

CAMP продажа от 20

SRTY смотрим на лонг

URI смотрим на продажу

EMES продажа ниже 95

TCS покупка от 16.50

Gapping up/down: COST +2% and YUM +1% after earnings, COTY +4% after upgrade; SAVE -3% and MON -2% after earnings/guidance, SAP -3% after reports of Job freeze, GPRO -2% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: COST +2.4%, YUM +1.3%

M&A news: TST +5% (to acquire BoardEx for ~$21 mln), SYMC +3.4% (may consider splitting up security and storage units, according to reports), AGN +1.9% (VRX and Pershing Square intend to increase bid for co), VRX +1.4% (co and Pershing Square intend to increase bid for Allergan (AGN)

Select financial related names showing strength: NBG +2%, ING +1.4%, SAN +1.4%, UBS +1.1%, HSBC +0.9%

Select metals/mining stocks trading higher: HL +3%, GFI +2.2%, AUY +1.6%, ABX +1.4%, IAG +1.3%, SLW +1.3%, GOLD +1.2%, SLV +1%, GDX +0.9%

Other news: GTAT +21.5% (seeing reports that co's first bankruptcy hearing has been scheduled for Thursday), SCOK +11.7% (issues update on construction and financing of underground Syngas Project), WYY +8.6% (receives 4 new federal contract awards; contract has period of performance of one year and total ~$2.7 mln), DRL +6.7% (disclosed the appointment of Nancy Reinhard as acting CFO), TST +5% (to acquire BoardEx for ~$21 mln), CMRX +4.9% (shows potential survival benefit in Adenovirus infection), PAH +3.7% (Pershing square disclosed a 26.1% active stake), TASR +3.7% (body camera momentum builds as adoption of AXON and EVIDENCE.com accelerates), OXGN +3% (announced first patient enrolled in Phase 1b/2 Study of Fosbretabulin combined with Pazopanib in patients with advanced recurrent ovarian cancer), MBLY +2.9% (ahead of TSLA event tomorrow), TKMR +2.5% (cont momentum/Ebola play), JCP +2.3% (ahead of anaylst day), ORAN +1.4% (in talks with other cos to create Netflix (NFLX) like streaming service, according to reports), BCRX +1.1% (present clinical trial results related to investigational drug RAPIVAB at the IDWeek Conference October 8-12)

Analyst comments: COTY +4.2% (upgraded to Neutral from Sell at B. Riley & Co), GLUU +2.3% (upgraded to Buy from Hold at The Benchmark Company), CMI +0.9% (initiated with a Buy at Stifel), LEAF +0.9% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: TILE -17.9%, (announces expansion of credit facility, planned bond redemption, share repurchase program ), SAVE -3.2%, (co sees Q3 adjusted operating margin in lower half of previous guidance range) MON -1.6%, RPM -1%, ASX -0.8%,.

Other news: RDY -4% (weak markets in India overnight), SAP -3.5% (reports suggesting job freeze until 2015 ), ICPT -3.2% (co decides not to present FLINT data at AASLD), RIO -2.1% (may still go after a defense deal with Anglo American (AAUKY), according to reports), INFY -1.5% (weak markets in India overnight), ALU -1.1% (still checking), GSK -0.8% (corruption allegations, according to reports out intraday), AZN -0.8% (may be in sympathy with GSK)

Analyst comments: SSNI -2.3% (downgraded to Neutral from Buy at Goldman), GPRO -2.2% (downgraded to Neutral from Overweight at Piper Jaffray), ARP -1.6% (initiated with a Mkt Perform at Raymond James)

Оригинал статьи: gtstocks.com/analytics-08-10-2014.html

Ближайший уровень поддержки по SPY – 196.00 уровень сопротивления – 197.25

Поздравляем всех с началом сезона отчетов. Вчера после закрытия рынка отчиталась положительно Alcoa Inc. Инвесторы могут положительно настроиться на рост рынка в ближайшие дни.

Alcoa — американская металлургическая фирма, 3-ий по величине производитель алюминия. Трехмесячный результат о деятельности данной фирмы, кой выходит 8 октября окажет мощное воздействие на цену акций.

GILD продажа от 109

AMGN продажа от 140

SSO продажа от 117

GOLD продажа ниже 70

URI покупка выше 103

DUST смотрим на лонг

Gapping up/down: RT +18% and AA +1.6% after earnings; AUXL +11% after merger ENDP, AGN +2.4% after upgrade; GPS -10% after guiding and CEO transition news, VOD -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance/SSS: RT +18.2%, DRWI +7.7%, EXAR +7.7%, LB +2.9%, AGN +2.4%, ZUMZ +1.8%, AA +1.6%, PEP +1.6%

M&A news: AUXL +10.7% (Endo (ENDP) to acquire Auxilium Pharmaceuticals in a cash and stock transaction for ~$2.6 bln, or $33.25 per share)

Select metals/mining stocks trading higher: PAAS +1.9%, SLV +1.6%, SSRI +1.2%, CDE +1.2%, AU +1%, HMY +0.9%, ABX +0.9%, GLD +0.7%, GDX +0.6%

Other news: SFXE +10.1% (announces that Chairman and CEO Robert F.X. Sillerman completed the purchase of 575k shares today), GTAT +10% (cont volatility), UAL +4.7% (reported September 2014 consolidated traffic decreased 0.2%, consolidated capacity decreased 0.4%), BLDP +4.4% (Ballard Power announces multi-year fuel cell supply agreement with Plug Power (PLUG) for forklift market), CGG +3.3% (reports vessel utilization and fleet allocation updates for third quarter 2014), NUAN +1.9% (rumors on Carl Icahn tweet — potential acquistion target), PLUG +1.3% (Ballard Power announces multi-year fuel cell supply agreement with Plug Power (PLUG) for forklift market), GNC +1.3% (positive mention on Wednesday's Mad Money)

Analyst comments: UAL +4.7% (added to Global Focus list at Credit Suisse), LPSN +2.6% (upgraded to Outperform from Neutral at Credit Suisse), AGN +2.4% (initiated with a Buy at Deutsche Bank), UTI +0.9% (upgraded to Outperform from Market Perform at Wells Fargo), TSLA +0.8% (ahead of D-day event, also added to Global Focus list at Credit Suisse), ROYT +0.8% (upgraded to Buy at Stifel), JCP +0.6% (Hearing defended at Piper Jaffray--reits Overweight rating), IIVI +0.6% (upgraded to Buy at DA Davidson)

Gapping down
In reaction to disappointing earnings/guidance: ARCW -18%, KFX -14.8%, GPS -9.7%, (also announces CEO transition news), EOPN -8.9%, DEST -1.4%,.

M&A news: ENDP -0.7% (Endo to acquire Auxilium Pharmaceuticals)

Select financial related names showing weakness: DB -3.2%, BCS -2.7%, SAN -2.7%, RBS -2%, HSBC -1.8%, LYG -1.4%

Select oil/gas related names showing early weakness: TOT -2.7%, RDS.A -2.4%, BP -1.4%, STO -1.3%, STO -1.3%, RIG -1%

Other news: PT -4.4% (still checking), ARWR -3.8% (higher following Deutsche Bank analyst appearance on CNBC defending the company, said today's sell off was over done), ONTX -3.2% (co filed for a $100 mln mixed securities shelf offering; co also filed for a 228,647 share common stock offering by selling shareholders), STV -2.2% (disclosed further update on its asset restructuring), X -0.8% (CAD $ 185 mln debtor financing facility approved, according to reports), TWTR -0.7% (Twitter's exec Vivian Schiller to leave the company with part of media consolidation, according to reports)

Analyst comments: HUB.B -5% (downgraded to Perform at Oppenheimer), ARWR -3.8% (downgraded to Sector Perform at RBC Capital Mkts), VOD -3.1% (downgraded to Reduce from Neutral at Nomura), ERIC -1.9% (reinstated with a Underperform at BofA/Merrill)

Оригинал статьи: gtstocks.com/analytics-09-10-2014.html

Ближайший уровень поддержки по SPY – 191.75 уровень сопротивления – 192.50

LAKE следим за недавним IPO

SRTY покупка выше 48

ERY покупка при удержании 20

SCO покупка выше 35.50

ERX смотрим на дальнейшее падение

APC ждем разворот выше 52

FSLR ниже 56 продажа, выше покупка

GPS продажа ниже 65.50

URI следим на открытии, возможен откат вверх

ROK покупка при удержании 103

CXO продажа ниже 109.50

EXP покупка при удержании 87

Gapping up/down: INFY +5% after earnings, EXAX +36% after positive CMS determination over Cologuard; MCHP -11%, MTW -9%, and JNPR -7% after earnings, Semis, oil and gold stocks trading lower Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: INFY +5.6%, HELE +3%, PLUG +2.7%

Other news: EXAS +35.8% (positive CMS determination over Cologuard), APT +26% (following 27% move higher yesterday with ongoing Ebola fears), SCMP +19.2% (Sucampo Announces Settlement Agreement That Resolves Patent Litigation in U.S. Related to AMITIZA), ALXA +16.8% (provided update on ADASUVE U.S. Commercial Progress; Alexza shipped 32,278 units in the third quarter, completing the ADASUVE initial product inventory stocking), CVEO +12.6% (Greenlight capital discloses 9.99% active stake in 13D filing), STV +6.9% (cont volatility pre-mkt), ISIS +5.3% (reports data from ISIS-SMN Rx Phase 2 studies in infants and children with spinal muscular atrophy), VNET +4.7% (establishes joint venture with Foxconn (FXCNY)), ARIA +3.7% (announced that Pharmacovigilance Risk Assessment Committee of EMA concluded review of Iclusig and has recommended that Iclusig continue to be used in Europe in accordance with its already approved indication), BX +2.7% (planning advisory spin-off, according to reports), ECOL +2.5% (to replace MEAS in the S&P SmallCap 600), OXLC +2.1% (adopted repurchase program of up to $35 mln worth of common stock), KGJI +1.6% (announces initial shipment of 24-karat gold jewelry product samples to Middle East)

Analyst comments: NDLS +0.9% (initiated with an Outperform at BMO Capital Mkts ), WDC +0.7% (initiated with a Buy at Jefferies), NRP +0.7% (upgraded to Outperform from Market Perform at Wells Fargo), BUD +0.5% (added to Conviction Buy List at Goldman)

Gapping down
In reaction to disappointing earnings/guidance: PKT -25.1%, VOXX -16.4%, SZMK -13.9%, MCHP -11.1%, KN -10.8%, MTW -8.9%, JNPR -7%, JOEZ -5%, FDO -1%

Select Semi names showing weakness: NXPI -4.4%, ATML -4.1%, STM -3.9%, LLTC -3.1%, ALTR -2.7%, ASML -2.1%, AVGO -2%, MU -1.9%

Select metals/mining stocks trading lower: CVE -3.3%, RIO -2.2%, GOLD -1.9%, AU -1.2%, GFI -1%

Select oil/gas related names showing early weakness: SDRL -2.5%, STO -2.2%, BHP -2.1%, TOT -1.7%, RIG -1.6%, HAL -0.4%

Other news: GTAT -29.5% (reportedly looking to close down its saphire business, according to court documents), TSLA -6.2% (following run-up into Model D event, also neg mention on Mad Money), MBLY -4.8% (news that new Tesla (TSLA) Model D will have self driving features), TKMR -3.4% (cont volatility), THLD -2.3% (disclosed that it has licensed rights to a development program from the University of Auckland based on the clinical-stage oncology compound Hypoxin; co expects to initiate a Phase 2 study of Hypoxin), RDS.A -2.3% (still checking), PTCT -2.3% (prices 3 mln shares of common stock at $36.25), SM -1.9% (sees Q3 production of 13.1 MMBOE, or 142.5 MBOE/d, at low end of previously provided guidance), SYMC -1.6% (announces new strategy to fuel growth and plans to separate into two public companies), GPRO -1.3% (founder Silicon Valley Community Foundation filed 13D), YHOO -1.2% (still checking), AMGN -1.1% (BiTE Immunotherapy Blinatumomab receives FDA Priority Review designation in acute lymphoblastic leukemia)

Analyst comments: BDSI -3.4% (downgraded to Hold from Buy at ROTH Capital), NDSN -3.4% (downgraded to Hold from Buy at BB&T Capital Mkts), GRPN -3.1% (downgraded to Sell from Equal Weight at Evercore), JCP -2.5% (downgraded to Sell at Maxim Group), ICLR -1.8% (downgraded to Neutral from Buy at ISI Group), BTI -1.2% (downgraded to Sell from Neutral at Goldman)

Оригинал статьи: gtstocks.com/analytics-10-10-2014.html

Ближайший уровень поддержки по SPY – 189.50 уровень сопротивления – 191.00

AVGO возможен откат вверх от 71

FFIV продажа ниже 107 выше 108 покупка

SVXY смотрим на откат вверх выше 62

SM при удержании 60,50 покупка

LRCX смотрим на покупку выше 66

CAVM следим за акцией

CPA продажа ниже 100,50

Gapping up/down: APL and ATLS +13% on M&A related news; Ebola related names trading higher, SPLK +2% on upgrade; LAD -10% and GY -3% after earnings, JCP and CLF -1% on dg's Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: MDXG +4.3%

M&A news: APL +12.8% (Targa Resources Partners and Targa Resources Corp. (TRGP) to acquire Atlas Pipeline Partners, L.P. (APL) and Atlas Energy, L.P. (ATLS)), ATLS +12.5%, CSX +9.2% (was approached for M&A deal with Canadian Pacific (CP) but CSX refused it, according to reports), TRGP +1.9%.

Select EU related names showing strength: NOK +2.3%, HSBC +2.1%, SAN +1.9%, YNDX +1.4%, RBS +1.1%, DB +0.9%

Select Ebola related stocks trading higher: IBIO +78.9% (outpacing strength seen this morning in most Ebola related names; checking around for company specific catalyst), HEB +20.6%, APT +18.7% (masks), LAKE +17.5% (masks), NLNK +4.7%, TKMR +4.1%, MLNX +2.2%, INO +1.1%, BCRX +0.7%, SIGA +0.7%

Select metals/mining stocks trading higher: MT +5%, RIO +4%, VALE +3.2%, BHP +2.7%, AU +2.3%, IAG +1.3%, GDX +1.3%, IAG +1.3%, ABX +1%

Select oil/gas related names showing strength: PBR +6.7%, SDRL +5.7%, TOT +1.6%, RIG +1.4%

Other news: DRL +66.4% (wins in Puerto Rico tax case), AHPI +7.6% (cont momentum), SHLD +4.9% (Kmart investigating payment system intrusion), AIXG +4.8% (Allianz Global Investors discloses 10.03% passive stake in 13G filing), KSU +2.6% (CSX peer), PXD +2.5% (Reliance Industries may sell PXD joint venture for $4.5 bln, according to reports), STO +1.5% (sells 15.5% share in Shah Deniz to Petronas for $2.2 bln), TASR +1.4% (announced four international orders — Australia, France, the UK, and Poland — for TASER brand next generation Smart Weapons).

Analyst comments: FOMX +8.3% (initiated with an Overweight at Barclays; initiated with a Outperform at Oppenheimer), GOLD +4.8% (upgraded to Buy from Neutral at UBS), TKAI +3.2% (initiated with an Outperform at William Blair), PRQR +3.2% (initiated with a Buy at H.C. Wainwright), SPWR +3% (upgraded to Outperform from Mkt Perform at Raymond James), SPLK +2.4% (upgraded to Outperform from Mkt Perform at William Blair), AZN +2.3% (upgraded to Buy from Hold at Jefferies), INFY +2% (upgraded to Buy form Hold at Deutsche Bank), TILE +2% (upgraded to Overweight from Equal Weight at Barclays), OUTR +1.9% (upgraded to Neutral from Sell at B. Riley & Co), SFUN +1.4% (upgraded to Buy from Hold at Deutsche Bank), TMUS +0.7% (upgraded to Outperform from Neutral at Macquarie)

Gapping down
In reaction to disappointing earnings/guidance: LAD -10.5%, GY -2.9%

M&A news: DG -1.2% (receives second request from FTC, as expected, regarding proposed acquisition of Family Dollar (FDO))

Other news: GTAT -23.5% (cont vol pre-mkt), LAD -10.5% (still checking), SFLY -7.9% (PE firm Silver Lake abandons attempt to acquire and combine Shutterly and Snapfish, according to reports), LUX -7.2% (Enrico Cavatorta to submit to the Board his resignation as CEO, also downgraded to Neutral from Buy at Citigroup), GPRO -1.8% (cont vol pre-mket), MBLY -1.2% (cautious Barrons mention)

Analyst comments: STM -2.3% (downgraded to Neutral from Overweight at JP Morgan, downgraded to Underweight from Equal-Weight at Morgan Stanley), NGD -1.8% (downgraded to Neutral from Overweight at JP Morgan), JCI -1.2% (downgraded to Outperform at RBC Capital Mkts), CLF -1% (downgraded to Neutral from Overweight at JP Morgan), JCP -1% (downgraded to Sell from Neutral at UBS), CME -0.5% (downgraded to Market Perform from Outperform at Wells Fargo)

Оригинал статьи: gtstocks.com/analytics-13-10-2014.html

Ближайший уровень поддержки по SPY – 186.00 уровень сопротивления – 188.00

NTCT смотрим на покупку, возможен откат

GILD покупка выше 96, ниже продажа

KMP продажа ниже 84

AWI покупка при удержании 46

PSX, TK, BCEI смотрим на покупку, возможен откат

AET покупка выше 74

ERX продажа ниже 64

XEC продажа ниже 104

CVX продажа ниже 109

MMP продажа ниже 71

SLB продажа ниже 88

Gapping up/down: CSX +2% and BAC +1% after earnings, CSRE +30% after merger with QCOM, Ebola names trading higher; LLTC -4% and INTC -1% after earnings, metals/miners trading lower, Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: SURG +4.7%, MTG +2.3%, CSX +1.8%, HPQ +1.8%, NHTC +1.5%, BLK +1.4%, BAC +0.7%, PNC +0.5%

M&A news: CSRE +30.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)

Select Ebola related names showing strength: APT +24.3%, LAKE +16.2%, IBIO +10%, HEB +6.3%, NLNK +6.1%, CERS +3.7%, CMRX +3.3%, SRPT +3.1%, TKMR +3%, INO +2.1%, NNVC +1.4%

Other news: ANN +8.2% (Golden Gate Capital files amended 13D with Confidentiality Agreement dated today Oct 14), NAVB +7.3% (FDA approves expanded use of Navidea's Lymphoseek for lymphatic mapping in solid tumors), GTAT +4.9% (Apple (AAPL) wants to secretly challenge GTAT bankruptcy, according to reports), MPO +4.3% (provides hedging update; 1212K barrels/day through 2Q15 at avg. ~$90/bbl), STRP +1.2% (after 18% move higher on earnings yesterday), SSRI +1.1% (analyst tour at Marigold highlights life of mine plan and exploration results), AMD +1.1% (in symp with INTC earnings), CCL +0.9% (Carnival and largest Chinese Shipyard sign Memo of Understanding aimed at growing the cruise industry in China),.

Analyst comments: PTEN +2% (initiated with a Buy at Citigroup), UNFI +1.9% (upgraded to Overweight from Neutral at Piper Jaffray), EXXI +1.5% (upgraded to Buy from Neutral at Global Hunter Securities), SWIR +1.1% (initiated with a Outperform at Northland Capital), CBS +1.1% (upgraded to Buy from Neutral at Citigroup), AMAT +0.8% (upgraded to Buy from Neutral at BofA/Merrill), RAX +0.6% (upgraded to Outperform from Sell at Credit Agricole), HST +0.5% (upgraded to Overweight from Equal Weight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: LLTC -3.7%, KEY -2.8%, INTC -1.1%, KTCC -1.1%

M&A news: SHPG -25.9% (notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), ABBV -3.9% (Announcement of notice to Shire Of AbbVie (ABBV) Board intention to reconsider recommendation), QCOM -0.5% (Qualcomm (QCOM) to acquire CSR for ~$2.5 bln)

Select EU related names showing weakness: SAN -3.5%, ALU -3.2%, BCS -2.7%, ALV -2.6%, NOK -2.5%, UBS -1.8%

Select metals/mining stocks trading lower: GFI -2.7%, RIO -2.3%, CDE -2.1%, MT -2.1%, VALE -1.8%, GOLD -1.2%, GDX -0.8%

Other news: CNET -10.3% (following 60%+ move higher yesterday), GWPH -4.9% (cont weakness), STAG -4.3% (announces public offering of 5 mln shares of common stock), NSPH -4.2% (following yesterday's 40% decline), STO -3.9% (president and CEO Helge Lund resigns), SNN -3.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), AZN -2.6% (likely attributed to tax inversion rules and fall out from SHPG/ABBV merger news), CUBE -2.2% (announces public offering of 6.5 mln common shares of beneficial interest), ESPR -1.4% (announces proposed public offering of $85 mln of common stock)

Analyst comments: RIG -2.2% (initiated with a Sell at ISI Group), OXY -0.6% (downgraded to Neutral from Outperform at Credit Suisse)

Оригинал статьи: gtstocks.com/analytics-15-10-2014.html

Ближайший уровень поддержки по SPY – 182.50 уровень сопротивления – 184.00

COV продажа от 86

FAS покупка от 84

Gapping up/downs: BGG +2% after earnings, CHK +6% after asset sale; NFLX -25% EBAY -3%, DAL and GS -2% after earnings, RIO -3% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: HCA +4.9%, UMPQ +3.5%, BGG +2.4%, HNI +2.3%, TSM +1.8%, URI +1.7%, NTCT +1.3%, KMP +0.8%

Select Ebola related names showing strength: CMRX +6%, SRPT +2.3%, LAKE +0.6%

Select metals/mining stocks trading higher: AU +1.9%, GG +1.1%, GG +1.1%, IAG +0.8%, IAG +0.8%, PAAS +0.6%, ABX +0.5%

Other news: EGLE +120.6% (completed financial restructuring; all existing equity interests cancelled), MSO +16.8% (Martha Stewart confirms multi-year media partnership with Meredith Corporation (MDP); will have an immediate impact on Operating Income), CVV +11.5% ((reported $27.5 mln in new orders through Q3, representing an increase of ~239% in new orders from prior year),), VIMC +6.2% (announced $39.80 mln contract wins in Taiyuan City of Shanxi province), APP +6% (seeing reports that co has made an interest payment on its bonds), CHK +5.9% (announces sale of Southern Marcellus and Utica Shale assets for proceeds of $5.375 bln), ANV +5.4% (announced preliminary Q3 production and sales: 49,630 ounces of gold produced vs 52,198 in prior year), ATEA +2.4% (filed timely appeal, which will stay the suspension of trading of its common stock on NASDAQ, pending the decision by a NASDAQ hearings panel), CPA +2.4% (announced monthly traffic statistics for September 2014: System-wde passenger traffic increased 1.9% yoy)

Analyst comments: SBGL +5.5% (upgraded to Neutral from Sell at UBS), BMRN +0.2% (initiated with a Buy at Sun Trust Rbsn Humphrey)

Gapping down
Briefing note: With the S&P Futures down nearly 1% in the pre-market, many stocks are gapping lower that are not listed.

In reaction to disappointing earnings/guidance: NFLX -25%, EXTR -22.9%, BHI -11.7%, ZHNE -6.3%, MAT -4.4%, EBAY -3.3%, BX -2.9%, DAL -2.7%, GS -2.4%, PM -1.8%, BBT -1.6%, KMI -1.5%, BAX -1.5%, AXP -1.4%, FCS -0.7%, UNH -0.5%

M&A news: SHPG -1.3% (AbbVie's (ABBV) Board recommends stockholders vote against Shire transaction)

Select financial related names showing weakness: DB -5.3%, ING -5.1%, SAN -4.8%, CS -4.5%, BCS -3.9%, C -2.2%, JPM -1.9%, WFC -1.7%, BAC -1.5%

Select energy stocks trading lower: STO -6.1%, HAL -5.2%, RDS.A -4.3%, TOT -3.8%, BP -2.8%

Select EU related names showing early weakness: ALU -5.7%, UBS -4.6%, MT -4.4%, DEG -4.4%, ORAN -4.3%, ASML -4.2%, PHG -4.1%, SAP -3.6%, YY -3.3%, VOD -3.2%, NVS -2.2%

Select Momentum names of interest: GPRO -5.2%, TSLA -4.2%, TWTR -3.1%, FB -2.3%, AAPL -1.7%

Other news: INSY -8.8% (receives DEA approval to produce pharmaceutical Cannabidiol; provides update on status of cannabinoid program ), ESPR -8.6% (prices 4.25 mln shares of common stock at $20.00 per share), TTPH -6.2% ( announces proposed public offering of common stock), GWPH -6.1% (cont weakness), SHLD -4.9% (announces commencement of rights offering), JKS -4.5% (signs 200 MW PV project development agreement with Government of Shicheng County in Jiangxi Province), RIG -4.4% (provided fleet status report: total value of new contracts since the September 22, 2014 update is ~$610 mln), AEG -3.9% (announces agreement to sell its Canadian Life Insurance Business for CAD$600 mln; expected to result in a book loss of ~CAD$1.2 bln), MHR -3.7% (closes on the previously announced definitive agreement to sell certain non-core assets), CSUN -3.6% (announces CFO Mr. Yongfei Chen's resignation and appoints Mr. Shiliang Guo as acting CFO), AMZN -3% (following EBAY results), BHP -2.2% (trading in symp with RIO)

Analyst comments: CGG -8.4% (downgraded to Reduce from Neutral at Nomura), SDRL -4.5% (downgraded to Reduce from Neutral at Nomura), AKAM -3.5% (downgraded to Market Perform from Outperform at Wells Fargo), RIO -3.2% (downgraded to Market Perform at Cowen ), DIS -1.8% (downgraded to Neutral from Buy at Guggenheim).

Оригинал статьи: gtstocks.com/analytics-16-10-2014.html

Ближайший уровень поддержки по SPY – 187.00 уровень сопротивления – 188.50

BPL продажа ниже 73,50

PPC смотрим на откат вверх

Gapping up/down: MS and GE +4% after earnings, NVS +2% after NICE draft guidance, AKS and SUNE +6% after upgrades; URBN -13%, SNDK -3% and GOOG -1% after earnings Price: null Change: null

Gapping up
Briefing note: With S&P futures up over 1% in the pre-market, many stocks are gapping higher that are not listed.

In reaction to strong earnings/guidance: QLGC +10.1%, (also Announces Approval of a $100 million Stock Repurchase Program), FHN +6.1%, XLNX +5.7%, CPHD +4.1%, MS +3.8%, GE +3.7%, WDFC +3%, SLB +2.6%, HON +1.9%

M&A news: HZNP +1.9% (announces acquisition of U.S. rights to PENNSAID 2% From Nuvo Research Inc. for $45 mln in cash), EXP +1.8% (to acquire CRS Proppants for ~$225 mln)

Select EU related names showing strength: ING +3.3%, ALU +3%, ASML +2.3%, CS +1.8%

Select Ebola related stocks trading higher: IBIO +11.6%, NLNK +5.1%, LAKE +4.9%

Select oil/gas related names showing strength: PBR +4.1%, STO +3.3%, SDRL +2.9%, HAL +2.2%

Select fan favorites trading higher: GPRO +4.6%, TSLA +2.2%, TWTR +2.1%, AAPL +1.3%

Other news: AMPE +16.3% (announces results of the open label portion of the multiple intra-articular injections study of Ampion), SRPT +9.7% (announces publication of Ebola and Marburg Phase I Clinical Study results in antimicrobial agents and chemotherapy), FMI +9.1% (announced an agreement to enhance precision medicine options for Priority Health members with advanced cancers, also upgraded to Outperform from Mkt Perform at William Blair), BEAT +7.8% (announces reinstatement of Cigna's coverage of Mobile Cardiac Monitoring Services), HCLP +6.1% (announced 9% increase in third quarter 2014 distribution to $0.625 per unit), PPC +2.9% (following weakness in poultry names on SAFM Investor Day comments), NVS +1.9% (NICE has issued final draft guidance proposing to recommend imatinib, also known as Glivec and made by NVS ), X +1.8% (may be in symp with AKS upgrade),.

Analyst comments: AKS +6.1% (upgraded to Buy from Neutral at Nomura), SUNE +5.7% (upgraded to Outperform from Mkt Perform at Cowen), EJ +5.6% (upgraded to Buy from Neutral at Goldman), NBR +2.2% (upgraded to Buy from Neutral at UBS), GS +1.5% (upgraded to Outperform from Mkt Perform at Keefe Bruyette), ISRG +0.9% (upgraded to Outperform at Leerink Partners)

Gapping down
In reaction to disappointing earnings/guidance: URBN -13.6%, (reports Q3 negative comparable retail segment net sale has continued quarter-to-date; gross profit margin may deleverage at a rate greater than during 1H), SNDK -2.8%, ATHN -2%, AMD -1.1%, GOOG -0.9%, COF -0.7%

M&A news: CF -3.9% (announced the termination of merger discussions with Yara International)

Other news: RPRX -40.6% (announces upcoming FDA meeting to be Type C meeting instead of Type B Pre-NDA meeting), CCL -3.4% (Health Care worker who may have handled Thomas Duncan's Ebola lab specimens has been isolated on CCL ship, according to reports), RCL -3% (in symp with CCL news), ANF -1.7% (following URBN guidance), AEO -1.2% (following URBN guidance), EARN -1.1% (co requested the withdrawal of its registration statement on Form S-11; intends to register on Form S-3)

Оригинал статьи: gtstocks.com/analytics-17-10-2014.html

Ближайший уровень поддержки по SPY – 190.50 уровень сопротивления – 192.25

SHLD продажа от 35

TSO продажа от 66

SOXL покупка выше 85

AAP смотрим на продажу

Gapping up/down: ILMN +9%, HOG +8%, TXN and AAPL +2% after earnings, PANW +1.5% after target raise; HAL +1% after upgrade; RMBS, -7%, ARMH -6%, KO -3% and MCD -2% after earnings, IBM -1% after dg Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: LXK +11%, ILMN +8.8%, HOG +7.8%, WERN +4.6%, CE +4.1%, CSL +3.7%, HLX +3.6%, WAT +2.5%, TXN +2.4%, AAPL +2.3%, AOS +2.3%, MBCN +2.2%, UTX +2%, STLD +1.9%, CDNS +1.1%, TRV +1.1%, ELS +0.9%, KMB +0.9%, CP +0.8%

M&A news: ACT +1.5% (Actavis and Sanofi (SNY) may be among bidders for Omega Pharma, according to reports).

Select EU financial related names showing strength: LYG +2.7%, RBS +2.5%, ING +2.3%, DB +0.8%.

Select metals/mining stocks trading higher: X 2.3%, MT 1.8%, AG 1.5%, GFI -0.5%.

Select oil/gas related names showing strength: STO +2.7%, SDRL +2.6%, BP +1.6%

Other news: NEON +22% (signs technology development agreement with global tier one printer OEM ), SGYP +13.1% (presents positive Phase 2b study results for Plecanatide in patients with irritable bowel syndrome), SCOK +5.6% (cont momentum), NXPI +2.6% (following TXN / AAPL results), GSAT +2.6% (co reiterated value of its spectrum assets; believes Kerrisdale continues to 'distort facts in attempt to undermine the benefits of TLPS'), TKMR +2.4% (cont momentum), CRUS +2.2% (following AAPL results), ABBV +2% (announced new $5 bln stock repurchase and increases dividend), BRCM +1.9% (following TXN results), RCL +1.9% (cont strength following yday's advance), TSL +1.7% (still checking), RFMD +1.5% (following AAPL results — component supplier), ACT +1.5% (Actavis and Sanofi (SNY) may be among bidders for Omega Pharma, according to reports), MU +1.4% (following TXN results), SUNE +1.4% (still checking), CCL +1.3% (cont strength following yday's advance), MGM +1.3% (still checking), MPW +1% (announced more than $1 billion in new real estate investments; expected to be accretive to normalized FFO by $0.09 — $0.12 per share), JEC +1% (awarded remediation task order for Eielson Air Force Base, Alaska worth ~$18.7 mln)

Analyst comments: POST +3.2% (upgraded to Buy from Neutral at Goldman), KITE +1.7% (target raised to $45 at Stifel), PANW +1.5% (target raised to $115 at Oppenheimer), COG +1.2% (upgraded to Outperform from Mkt Perform at Bernstein), HAL +1.2% (upgraded to Buy from Neutral at Guggenheim), EOG +0.5% (upgraded to Buy from Neutral at Guggenheim)

Gapping down
In reaction to disappointing earnings/guidance: GLF -8%, RMBS -6.9%, KALU -6.8%, UCTT -6.3%, ARMH -5.9%, APOL -5.4%, CMG -5.2%, XRS -3.3%, KO -3.1%, PKG -2.5%, CYS -1.6%, RCII -1.6%, LMT -1.6%, MCD -1.5%, IHG -1%, ZION -0.9%, BRO -0.9%, VZ -0.8%,.

Select Brazil related names showing weakness: OIBR -8.2%, PBR -7.7% SID -3.5%, VIV -2.8%, ELP -2.5%, GGB -2.2%, SBS -2.1%, VALE -1.7%, ABEV -1.4%.

Other news: RNO -42.8% (announces Q3 distribution of $0.05 per unit, lowered from previous quarter distribution of $0.445 per unit; co redoubling its cost cutting efforts due to weak coal markets), IBIO -20.2% (cont volatility), CVM -17.6% (announces proposed public offering of Common Stock; terms not disclosed), OMER -15% (provides update on PDE10 inhibitor program; enrollment in Huntington's Trial suspended pending further assessment of preclinical data), PT -8.3% (still checking, but Oi SA announces liquidation of assets will have no impact on the business combination with Portugal Telecom), LAKE -2.9% (cont weakness), TLLP -2% (prices upsized public offering of 20 mln common units at $57.47 per unit), SPLS -1.8% (spokesman has indicated company is investigating possible data breach, according to reports), ENTA -1.7% (provides update on its collaboration agreement with AbbVie (ABBV); co-development option on next-generation Protease Inhibitor ABT-493 Not Exercised, net sales allocations for ABT-450-containing regimens finalized), PHG -1.7% (cont weakness), REN -1.4% (provides operation update: Three Permian Basin horizontal wells averaged 1,300 Boe per day on peak 24-hour IP tests), GSK -1.3% (still checking), TRN -1.2% (late sell-off on guardrails ruling; confirms $175 mln in damages at jury trial)

Analyst comments: PHG -1.7% (downgraded to Neutral from Buy at UBS), IBM -0.7% (downgraded to Hold from Buy at Evercore; target lowered to $170 at RBC Capital Mkts), IRC -0.6% (downgraded to Underperform from Neutral at BofA/Merrill), ED -0.4% (downgraded to Underweight at Morgan Stanley)

Оригинал статьи: gtstocks.com/analytics-21-10-2014.html

Ближайший уровень поддержки по SPY – 193.50 уровень сопротивления – 195.00

NLNK выше 41 покупка, ниже продажа

IRB ниже 36,50 продажа

DUST смотрим на покупку

TLLP покупка выше 58

ASPS смотрим на откат вверх

Gapping up/down: NOK +9%, CAT +4% and GM +2% after earnings, BABA +1% after initiation at Overweight; YELP -12%, CAB -10%, CTXS -6% and UA -4% after earnings Price: null Change: null

Gapping up
In reaction to strong earnings/guidance: JAKK +16.2%, EGHT +13.4%, SCSS +13.3%, TSCO +12.6%, INFN +12.6%, DAN +9.8%, NOK +8.7%, ACTG +8.3%, LCI +7.3%, PLCM +6.2%, LOGI +5.7%, YNDX +5.2%, JNS +5.2%, MKTO +4.5%, DO +4.4%, CAT +4.4%, ORAN +4.2%, SLM +4%, ORLY +3.9%, MLNX +3.5%, SHLM +3.3%, (following late move lower), ALXN +3%, FTNT +2.9%, LUV +2.7%, MMM +2.2%, NXPI +2.1%, SFG +2%, CSH +2%, BBW +2%, UNP +1.9%, NOW +1.8%, GM +1.7%, DMRC +1.6%, AB +1.6%, JBLU +1.5%, SGMO +1.4%, ORRF +1.3%, CAM +1.2%, RTN +1.1%, CMCSA +1%, CHKP +0.9%

M&A news: BRP +21.3% (Brookfield Asset Mgmt proposes to acquire 30% of Brookfield Residential Properties (BRP) not currently owned for $23.00/share), WWAV +7.2% (WhiteWave Foods or Boulder Brands (BDBD) may be possible takeover targets, according to Bloomberg real M&A column), PETM +3.1% (has received takeover interest from KKR (KKR) and outer PE firms, according to reports)

Other news: CYTX +50% (received FDA approval to resume ATHENA trial enrollment), VIMC +8.4% (announces $29.2 million contract win in Chenzhou city of Hunan province), KNDI +5% (still checking), PH +4.5% (increases quarterly dividend 31 percent and authorizes the repurchase of up to 35 million shares), RGLS +3.3% (after doubling yesterday), ERIC +3% (in symp with NOK), GPRO +2.9% (still checking), ING +2.1% (in symp with CS), BBRY +2.1% (trading higher, may be on NOK earnings, but also a story that co is unlikely to be acquired by Lenovo (LNVGY), according to reports), CSH +2% (approved the spin-off of its E-Commerce Division, Enova International, Inc., into an independent and separate publicly traded company), STX +1.7% (raises targeted annual dividend), UBS +1.7% (in symp with CS), CPXX +1.7% (pricing of a $12.9 million public offering of common stock at $1.95/unit and warrants to purchase common stock at $3.58/whole share and will have a term of five years), TWTR +1.5% (presented at Mobile Developer conf yday), V +1.3% (declared a quarterly dividend in the aggregate amount of $0.48 per share, a 20% increase), TSLA +1.2% (to enter Australia market, accoridng to reports), KMX +1% (raises share repurchase authorization by $2 bln), LYG +0.8% (plans to eliminate 9000 jobs, according to reports)

Analyst comments: ALU +6% (upgraded to Hold from Underperform at Jefferies), LUX +2.3% (upgraded to Buy from Hold at Berenberg), DOW +2% (upgraded to Buy from Hold at Deutsche Bank), BABA +1.1% (initiated with an Overweight at Barclays), ABBV +1% (resumed with a Overweight at JP Morgan), GSK +0.9% (upgraded to Overweight from Equal Weight at Barclays)

Gapping down
In reaction to disappointing earnings/guidance: AIRM -24.3%, YELP -12.5%, CAB -9.6%, CLB -6.8%, CTXS -6.6%, IPCM -6.2%, AWH -4.7%, (light volume), CAKE -4.5%, VAR -4.3%, ACAT -4%, UA -4%, OTEX -3.9%, DNKN -3.8%, TER -2.2%, SUSQ -2.1%, UN -1.9%, GOL -1.7%, LRCX -1.5%, WFT -1.5%, CA -1.3%, T -1%, PCP -1%, CCE -0.8%

Other news: ADHD -14.1% ( released a presentation with updated clinical trial results of Metadoxine Extended Release for the treatment of ADHD), FREE -9.1% (filed for 17,500,000 shares common stock, offering by selling stockholder), PT -5.4% (still checking), NMFC -3.8% (commences offering of 5,000,000 shares of common stock), WYY -3.7% (prices public offering of 6,896,552 shares of common stock at $1.45/share), ZAZA -1% (following 40% move higher yesterday), ISNS -0.9% (following 30% move higher yesterday), SPEX -0.8% (provides litigation update)

Analyst comments: MDCO -1.5% (downgraded to Neutral from Buy at BofA/Merrill)

Оригинал статьи: gtstocks.com/analytics-23-10-2014.html

Ближайший уровень поддержки по SPY – 201.00 уровень сопротивления – 202.50

CVX смотрим на продажу ниже 100

HLF покупка выше 48

AMBA продажа от 48

BABA отчет

WDC продажа от 101

AVB покупка выше 158

LH смотрим на откат вверх

CME покупка выше 85

Оригинал статьи: gtstocks.com/analytics-04-11-2014.html

Ближайший уровень поддержки по SPY – 201.50 уровень сопротивления – 202.50

BABA следим

GPN покупка выше 82,80 ниже на продажу

MSI продажа от 67

SALE покупка выше 15

KEX смотрим на откат вверх

Оригинал статьи: gtstocks.com/analytics-05-11-2014.html

Ближайший уровень поддержки по SPY – 201.90 уровень сопротивления – 202.25

CRTO смотрим на продажу

MGA продажа от 103 или ниже 102

DVN продажа от 62

EQT покупка на продолжение тренда вверх 97

NEE продажа от 105

SSYL покупка выше 109

LMCA,TRIP смотрим на покупку

Новостные акции:
PNK, BYD, AEGR, PT, GSB, GPRO, FEYE, DEG, RGP, EVOL, PRGO, AEZS, BAH, PKT

Оригинал статьи: gtstocks.com/analytics-06-11-2014.html

Ближайший уровень поддержки по SPY – 203.00 уровень сопротивления – 203.50

HLF следим за акцией

BABA продолжается сильный рост

CLF покупка выше 12

LMCA покупка выше 35,50

NUS покупка выше 41

Новостные акции

ROKA, ACHN, OIBR, GILD, BBRY, NADL, BABA, BMRN, GOGO, KWK, DNDN, ANF

Оригинал статьи: gtstocks.com/analytics-10-11-2014.html

Ближайший уровень поддержки по SPY – 204.00 уровень сопротивления – 204.25

AGIO продажа от 82, выше покупка

CHTR смотрим на покупку

TWC покупка выше 137

RYN смотрим на продажу

Новостные акции:
RAX, QIWI, ANIK, IMAX, RIO, VALE, BABA

Ближайший уровень поддержки по SPY – 203.80 уровень сопротивления – 204.30

BHI смотрим на откат вниз

TWC продажа от 141,50

WMT продажа от 82,50

CHTR смотрим на покупку от 152

DWA смотрим на продажу

BA продажа от 128,50

YY смотрим на покупку

ASPS смотрим на покупку

Новостные акции:
SPU, CRR, TUBE, USAT, FRSH, HOLI, BONA, DEJ, JWN, WB, YOD, MOV, RTRX, RCON, SID, BBD, ABGB, OCN, PBR, LULU

Ближайший уровень поддержки по SPY – 205.50 уровень сопротивления – 207.50

WLL,ERX смотрим на откат с открытия

RCPT продажа от вчерашнего хая дня

DDS продажа ниже 120

WSM продажа от 76

EXP выше 92 покупка, ниже продажа

LL продажа от 59

ASPS смотрим на покупку

GMCR покупка от 144

GPRO смотрим на покупку

Новостные акции:
SPLK, ROST, FL, GME, ARUN, LRAD, BBD, PBR, WLT, CLF, VALE. RIO. BHP, SSL, SFUN, BID, BABA, TRN, BBY

Дорогие друзья!

Нам исполнилось уже 3 года! Руководители компании благодарны всем партнерам нашей компании, которые все эти годы были с нами и трудились ради достижения высокой цели — стать лучшими.

За этот небольшой период времени мы приобрели истинных друзей, которые всегда поддерживали нас и помогали нам. Мы хотим поблагодарить их за это и надеемся на долгосрочное сотрудничество еще не один год!

Мы надеемся, что и впредь нашей компании будет сопутствовать успех и удача! Поздравляем с этим замечательным праздничным днем Всех партнеров компании, группы трейдеров, брокеров, клиентов и трейдеров которые так или иначе имеют отношение к нашей компании. Спасибо, что Вы есть у нас, доверяете нам и у нас сложились не только партнерские отношения, но и дружеские.

В связи с этим, компания объявляет запуск акции:

Всем новым клиентам компании торговый терминал Такион бесплатно весь декабрь и январь!
Комиссия для новых клиентов до 1 февраля — 3$ за 1 000 акций на терминале Takion

Так же мы сделали исключение в этот праздник и для наших клиентов:

При переходе с торгового терминала Fusion или Sterling на Takion до 1 февраля комиссия в 3$ за 1 000 акций
Для всех замороженных аккаунтов, при активации, пополнении счета от 500 долларов и переходе на торговый терминал Takion комиссия до 1 февраля — 3$ за 1 000 акций

Время действия акции ограничено, торопитесь воспользоваться торговыми условиями! Подробности можно узнать у наших менеджеров.

Оригинал статьи: http://gtstocks.com/3years.html

Ближайший уровень поддержки по SPY – 203.00 уровень сопротивления – 204.00

SCO смотрим на покупку

JNUG, UHS следим за акциями

ALKS покупка выше 69

SLG продажа от 128

BITA покупка выше 74

TIF покупка выше 90

SNDK покупка выше 84

CLB смотрим на откат вверх, при удержании 104

Оригинал статьи: gtstocks.com/analytics-13-01-2015.html